ReviewEuropean clinical respiratory journal2026
The association between asthma and heart failure - a systematic review and meta-analysis.
Review in European clinical respiratory journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aim: Asthma and heart failure are highly prevalent diseases with substantial impact on quality of life and life expectancy. Studies have reported on the association between cardiovascular diseases and asthma. The aim of this review is to provide an update on the current evidence for an association between asthma and heart failure (HF) with regard to prevalence and outcome. Methods: A systematic literature search, last updated in ultimo May 2025, was performed on PubMed in accordance with the PRISMA guidelines. The identified articles were systematically screened for eligibility. A random-effects meta-analysis was performed to pool hazard ratios and odds ratios for HF in asthma patients. Results: A total of 11 studies were included. Four studies found that asthma was statistically significantly associated with an increased risk of HF. Two studies found a non-significantly increased risk of HF in asthma patients. The pooled HR for HF incidence in asthma patients was 2.03 (95% CI: 1.55; 2.68). Similarly, the pooled OR was 1.61 (95% CI: 1.09; 2.38). Three studies found increased morbidity and mortality in asthma patients with HF compared to controls. One study showed a non-significant increase in mortality in patients with concomitant asthma and HF, whereas another reported a decreased risk compared to HF alone. Conclusions: The available evidence suggests a significant association between asthma and incident HF, as well as an increased risk of hospitalization in patients with both conditions, even after adjusting for sex, age, and other known cardiovascular risk factors.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.